Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.22.4
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of stock-based compensation
    For the Years Ended
December 31,		  
    2022     2021  
Research and development   $ 81,706     $ 223,476  
General and administrative     1,582,205       2,320,236  
Total   $ 1,663,911     $ 2,543,712  

 
Schedule of stock options outstanding and exercisable
                Weighted Average     Aggregate  
    Stock Options     Exercise Price     Fair Value     Contractual     Intrinsic  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Value  
Balance – January 1, 2021     248,997       179,682     $ 61.80     $ 50.40     $ 50.40       6.27     $
            -
  
Granted     210,467       42,181       39.72       40.73       17.95       6.27      
-
  
Exercised     (42,072 )    
-
      
-
      
-
      
-
      
-
      
-
  
Cancelled     (50,981 )    
-
      
-
      
-
      
-
      
-
      
-
  
Balance – December 31, 2021     366,411       204,230     $ 51.30     $ 47.40     $ 47.40       6.27     $
-
  
Granted     19,367       694       10.42       10.42       4.53       6.27      
-
  
Exercised    
-
      
-
      
-
      
-
      
-
      
-
      
-
  
Cancelled     (67,921 )    
-
      
-
      
-
      
-
      
-
      
-
  
Balance – December 31, 2022     317,857       194,853     $ 45.38     $ 38.65     $ 38.65       6.27     $
-
  

 
Schedule of stock option activity
Grant Price     Weighted Average     Total     Number     Weighted Average
From     To     Exercise Price     Outstanding     Exercisable     Remaining Contractual Term
$ 6.00     $ 60.60     $ 34.32       268,357       147,218     7.20 years
$ 63.00     $ 138.00     $ 78.22       38,066       36,201     5.01 years
$ 159.00     $ 265.80     $ 172.14       11,434       11,434     5.32 years
                  Totals       317,857       194,853      

 
Schedule of warrant activity
                Weighted Average     Aggregate  
    Warrants     Exercise Price     Fair Value     Contractual     Intrinsic  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Value  
Balance – January 1, 2021     645,761       516,532     $ 48.60     $ 48.30     $ 24.30       4.07     $
-
  
Granted     696,444      
-
      
-
      
-
      
-
       -      
-
  
Exercised     (48,368 )    
-
      
-
      
-
      
-
       -      
-
  
Cancelled     (106,035 )    
-
      
-
      
-
      
-
       -      
-
  
Balance – December 31, 2021     1,187,803       1,187,664     $ 31.20     $ 31.20     $ 15.90       4.38     $
-
  
Granted    
-
      
-
      
-
      
-
      
-
       -      
-
  
Exercised    
-
      
-
      
-
      
-
      
-
       -      
-
  
Cancelled     (9,634 )    
-
      
-
      
-
      
-
       -      
-
  
Balance – December 31, 2022     1,178,169       1,178,169     $ 30.67     $ 30.67     $ 17.83       3.41     $              -